Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-70,000
Closed -$2.12M 5086
2025
Q4
$2.12M Buy
70,000
+45,000
+180% +$1.1M ﹤0.01% 2892
2025
Q3
$495K Buy
+25,000
New +$523K ﹤0.01% 3817
2025
Q2
Sell
-96,200
Closed -$2.25M 5286
2025
Q1
$2.25M Sell
96,200
-93,800
-49% -$2.72M ﹤0.01% 2546
2024
Q4
$5.31M Buy
190,000
+24,300
+15% +$651K ﹤0.01% 2102
2024
Q3
$3.38M Buy
165,700
+139,300
+528% +$3.12M ﹤0.01% 2418
2024
Q2
$780K Sell
26,400
-87,000
-77% -$2.5M ﹤0.01% 2753
2024
Q1
$3.46M Buy
113,400
+7,700
+7% +$217K ﹤0.01% 2105
2023
Q4
$2.47M Sell
105,700
-182,300
-63% -$4.41M ﹤0.01% 2745
2023
Q3
$8.53M Buy
288,000
+134,400
+88% +$4.5M 0.01% 1057
2023
Q2
$5.42M Sell
153,600
-106,400
-41% -$2.98M ﹤0.01% 1303
2023
Q1
$6.26M Buy
+260,000
New +$6.03M ﹤0.01% 1410

Other funds holding CFLT

Barclays's CFLT Position: Q1 2026 in Review

Barclays sold out of Confluent (CFLT) in Q1 2026, closing a stake of 84,669 shares — an estimated $2.56M sold.

Barclays first reported a position in CFLT in Q1 2022 and held it in 16 quarters. The position peaked at $28.8M in Q4 2022. 4 funds tracked by Wall St. Rank hold CFLT as of Q1 2026.

  • Barclays reported no remaining Confluent position as of Q1 2026 after selling out during the quarter.
  • Barclays sold 84,669 Confluent shares in Q1 2026, an estimated $2.56M.
  • Barclays first reported a position in Confluent in Q1 2022 and held it in 16 quarters.
  • Barclays's Confluent position peaked at $28.8M in Q4 2022.
  • 4 funds tracked by Wall St. Rank held Confluent as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.